Page last updated: 2024-08-24

loxiglumide and Atypical Ductal Hyperplasia

loxiglumide has been researched along with Atypical Ductal Hyperplasia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baba, N; Hayashi, H; Hosokawa, Y; Kawabata, K; Manabe, T; Masai, Y; Morimoto, H; Nio, Y; Tseng, CC; Tsubono, M	1

Other Studies

1 other study(ies) available for loxiglumide and Atypical Ductal Hyperplasia

Article	Year
Inhibitory effects of a cholecystokinin antagonist, loxiglumide (CR-1505), on the growth of freshly separated and xenografted human pancreatic cancer. Journal of surgical oncology, 1993, Volume: 53, Issue:1 Topics: Animals; Carcinoma, Intraductal, Noninfiltrating; Cholecystokinin; DNA, Neoplasm; Dose-Response Relationship, Drug; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Pancreatic Neoplasms; Proglumide; RNA, Neoplasm; Transplantation, Heterologous; Tumor Cells, Cultured	1993

Article

Year

Inhibitory effects of a cholecystokinin antagonist, loxiglumide (CR-1505), on the growth of freshly separated and xenografted human pancreatic cancer.

Journal of surgical oncology, 1993, Volume: 53, Issue:1

Topics: Animals; Carcinoma, Intraductal, Noninfiltrating; Cholecystokinin; DNA, Neoplasm; Dose-Response Relationship, Drug; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Pancreatic Neoplasms; Proglumide; RNA, Neoplasm; Transplantation, Heterologous; Tumor Cells, Cultured

1993